Merck & Co., Inc. is 342.6x more valuable than Olema Pharmaceuticals, Inc. by market capitalization ($293.16 B vs $855.57 M). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | OLMA | MRK |
|---|---|---|
| Market cap | $855.57 M | $293.16 B |
| US-listed rank | #2661 | #44 |
| Revenue (latest FY) | - | $65.01B |
| Net income (latest FY) | -$162.45M | $18.25B |
| Net margin | - | 28.1% |
| P/E (trailing FY) | - | 16.1 |
| SEC filings | 538 | 996 |
Merck & Co., Inc. is 342.6x more valuable than Olema Pharmaceuticals, Inc. by market capitalization ($293.16 B vs $855.57 M).
Full pages: Olema Pharmaceuticals, Inc. and Merck & Co., Inc., or browse the full rankings.